Decreased production of collagen type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: Possible implication of MMP-3

Journal of Vascular Research

Volumn 42, Issue 5, 2005, Pages 388-398

  Sansilvestri Morel, Patricia ^a   Rupin, Alain ^a   Jullien, Nicolas D ^a   Lembrez, Nathalie ^a   Mestries Dubois, Patricia ^a   Fabiani, Jean Noël ^b   Verbeuren, Tony J ^a,c  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Collagen III; Fibronectin; Matrix metalloproteinase 3; Varicose veins

Indexed keywords

COLLAGEN TYPE 3; FIBRONECTIN; MARIMASTAT; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS REGULATION; SMOOTH MUSCLE FIBER; STEADY STATE; VARICOSIS;

AGED; AGED, 80 AND OVER; CELL COMPARTMENTATION; CELLS, CULTURED; COLLAGEN TYPE III; EXTRACELLULAR SPACE; FEMALE; FIBRONECTINS; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOLLAGEN; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEASE INHIBITORS; PROTEIN BIOSYNTHESIS; RNA STABILITY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR; VARICOSE VEINS;

EID: 25444526347     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087314     Document Type: Article

References (35)

1. Waksman Y, Mashiah A, Hod I, Rose SS, Friedman A: Collagen subtype pattern in normal and varicose saphenous veins in human. Isr J Med Sci 1997;33:81-86.
2. Khan A, Refaat AE, Hamdi A: Structural changes in the tunica intima of varicose veins: a histopathological and ultrastructural study. Pathology 2000;32:253-257.
3. Badier-Commander C, Couvelard A, Henin D, Verbeuren TJ, Michel J-B, Jacob M-P: Smooth muscle cell modulation and cytokine overproduction in varicose veins: an in situ study. J Pathol 2001;193:398-407.
4. Rose SS, Ahmed A: Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg 1986;27:534-543.
5. Kirsch D, Dienes HP, Küchle R, Duschner H, Böttger T, Junginger T: Changes in the extracellular matrix of the vein wall: the causes of primary varicosis? VASA 2000;29:173-177.
6. Cornu-Thenard A, Boivin P, Baud JM, De Vincenzi I, Carpentier PH: Importance of the familial factor in varicose disease. J Dermatol Surg Oncol 1994;20:318-326.
7. Pistorius MA: Chronic venous insufficiency: the genetic influence: Angiology 2003;54:S5-S12.
8. Sansilvestri-Morel P, Rupin A, Badier-Commander C, Kern P, Fabiani J-N, Verbeuren TJ, Vanhoutte PM: Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res 2001;38:560-568.
9. Sansilvestri-Morel P, Rupin A, Badier-Commander C, Fabiani J-N, Verbeuren TJ: Chronic venous insufficiency: dysregulation of collagen synthesis: Angiology 2003;54:S13-S18.
10. Sansilvestri-Morel P, Nonotte I, Fournet-Bourguignon MP, Rupin A, Fabiani J-N, Verbeuren TJ, Vanhoutte PM: Abnormal deposition of extracellular matrix proteins by cultured smooth muscle cells from human varicose veins. J Vasc Res 1998;35:115-123.
11. Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani J-N, Verbeuren TJ, Vanhoutte PM: Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002;106:479-483.
12. Hayashi T, Nagai Y: Separation of the α chains of type I and III collagens by SDS-polyacrylamide gel electrophoresis. J Biochem 1979;86:453-459.
13. Kern P, Moczar M, Robert L: Biosynthesis of skin collagens in normal and diabetic mice. Biochem J 1979;182:337-345.
14. De Paepe A: Ehlers-Danlos syndrome type IV. Dermatology 1994;189:21-25.
15. Tromp G, Kuivaniemi H, Stolle C, Pope FM, Prockop J: Single base mutation in the type III procollagen gene that converts the codon for glycine 883 to aspartate in a mild variant of Ehlers-Danlos syndrome IV. J Biol Chem 1989;264:19313-19317.
16. Utani A, Tanaka T, Nishigori C, Miyachi Y, Danno K, Imamura S, Hosokawa M, Takeda T, Hirayoshi K, Nagata K: Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen. Lab Invest 1990;63:181-188.
17. Thakker-Varia S, Anderson DW, Kuivaniemi H, Tromp G, Shin HG, van der Rest M, Glorieux FH, Ala-Kokko L, Stolle CA: Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV. Hum Mutation 1995;6:116-125.
18. Lees TA, Mantle D, Lambert D: A comparison of smooth muscle derived proteolytic enzymes in normal and varicose veins. Phlébologie 1992;92:49-51.
19. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ: Matrix metalloproteases inhibitors. Invest New Drugs 1997;15:61-75.
20. Lijnen HR: Plasmin and Matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001;86:324-333.
21. Silence J, Collen D, Lijnen HR: Persistance of atherosclerotic plaque and reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001;21:1440-1445.
22. Saarialho-Kere UK: Pattern of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 1998;290(suppl):S47-S54.
23. 1. J Biol Chem 2002;277:37377-37381.
24. Ohashi T, Kiehart DP, Erickson HP: Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein. Proc Natl Acad Sci USA 1999;96:2153-2158.
25. Kim HS, Shang T, Chen Z, Pflugfelder SC, Li DQ: TGF-beta1 stimulates production of gelatinase (MMP-2,-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, MMP-10, MMP-11) by human corneal epithelial cells. Exp Eye Res 2004;79:263-274.
26. Kanaki T, Bujo H, Mori S, Yanjuan Z, Takahashi K, Yokote K, Morisaki N, Saito Y: Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3. Biochem Biophys Res Commun 2002;294:231-237.
27. -/- microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2). J Cell Biochem 2003;90:1015-1025.
28. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, Saito Y: Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003;46:1483-1488.
29. Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181:902-906.
30. Blomgren L, Johansson G, Siebahn A, Bergqvist D: Coagulation and fibrinolysis in chronic venous insufficiency. VASA 2001;30:184-187.
31. Bujan J, Jurado F, Gimeno MJ, Garcia-Honduvilla N, Pascual G, Jimenez J, Bellon JM: Changes in metalloproteinase (MMP1, MMP2) expression in the proximal region of the varicose saphenous vein wall in young subjects. Phlebology 2000;15:64-70.
32. Gillespie DL, Patel A, Fileta B, Chang A, Barnes S, Flagg A, Kidwell M, Villavicencio JL, Rich NM: Varicose veins possess greater quantities of MMP1 than normal veins and demonstrate regional variation in MMP1 and MMP13. J Surg Res 2002;106:233-238.
33. Kowalewski R, Sobolewski K, Wolanska M, Gacko M: Matrix metalloproteinases in the vein wall. Int Angiol 2004;23:164-169.
34. Parra JR, Cambria RA, Hower CD, Dassow MS, Freischlag JA, Seabrook GR, Towne JB: Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the legs. J Vasc Surg 1998;28:669-675.
35. Badier-Commander C, Verbeuren TJ, Lebard C, Michel J-B, Jacob M-P: Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol 2000;192:105-112.